α-Adrenoceptors and benign prostatic hyperplasia: basic principles for treatment with α-adrenoceptor antagonists

ISSN： 0724-4983

Source： World Journal of Urology, Vol.19, Iss.6, 2002-04, pp. : 390-396

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Increased Bladder Apoptosis with α-1 Adrenoceptor Antagonists in Benign Prostatic Hyperplasia

By Erdoğru T. Gülkesen K. H. Kukul E. Yalçinkaya M. Karpuzoğlu G. Baykara M.

Scandinavian Journal of Urology and Nephrology, Vol. 36, Iss. 3, 2002-06 ,pp. : 188-193

Informa Healthcare

Access to resources Recommend Favorite

Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia

By Bartsch G. Rittmaster R. Klocker H.

World Journal of Urology, Vol. 19, Iss. 6, 2002-04 ,pp. : 413-425

Springer Publishing Company

Access to resources Recommend Favorite

Laser treatment of benign prostatic hyperplasia

By Kuntz Rainer

World Journal of Urology, Vol. 25, Iss. 3, 2007-06 ,pp. : 241-247

Springer Publishing Company

Access to resources Recommend Favorite

Lasers in the treatment of benign prostatic hyperplasia

By Gerber G.S.

Urology, Vol. 45, Iss. 2, 1995-02 ,pp. : 193-199

Elsevier

Access to resources Recommend Favorite

A comparison of four different α1-blockers in benign prostatic hyperplasia patients with and without diabetes

By Bozlu Murat Ulusoy Ercüment Çayan Selahittin Akbay Esen Görür Sadık Akbay Erdem

Scandinavian Journal of Urology and Nephrology, Vol. 38, Iss. 5, 2004-11 ,pp. : 391-395

Informa Healthcare

Access to resources Recommend Favorite